{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:14:35Z","timestamp":1760188475380},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.amjcard.2004.11.041","type":"journal-article","created":{"date-parts":[[2005,3,8]],"date-time":"2005-03-08T18:29:05Z","timestamp":1110306545000},"page":"791-795","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of the safety and efficacy of emboli prevention devices versus platelet glycoprotein IIb\/IIIa inhibition during carotid stenting"],"prefix":"10.1016","volume":"95","author":[{"given":"Albert W.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Bajzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Gum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramtin","family":"Agah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Topol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2004.11.041_bib1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa040127","article-title":"Protected carotid-artery stenting versus endarterectomy in high-risk patients","volume":"351","author":"Yadav","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.11.041_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199108153250701","article-title":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.11.041_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.amjcard.2004.11.041_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.95.2.376","article-title":"Elective stenting of the extracranial carotid arteries","volume":"95","author":"Yadav","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.11.041_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis In Myocardial Infarction (TIMI) Trial\u2013phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.11.041_bib6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(94)90007-8","article-title":"Randomised trial of coronary intervention with antibody against platelet IIb\/IIIa integrin for reduction of clinical restenosis: results at six months","volume":"343","author":"Topol","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.11.041_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.11.041_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","article-title":"Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors","volume":"341","author":"Lincoff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.11.041_bib9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.11.041_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","article-title":"Recognition of the importance of embolization in atherosclerotic vascular disease","volume":"101","author":"Topol","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.11.041_bib11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","author":"Topol","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.11.041_bib12","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1067\/mhj.2000.103742","article-title":"Clinical challenges of platelet glycoprotein IIb\/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment","volume":"139","author":"Tcheng","year":"2000","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904018946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914904018946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T20:43:56Z","timestamp":1549572236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914904018946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0002914904018946"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2004.11.041","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}